London, 15 September 2014 – TechNavio, a global tech-focused research firm has announced the publication of its market research report on the Global Antibiotics Market 2014-2018.
Antibiotics work against microorganisms such as bacteria, fungi and protozoans, but are not effective against viruses. Antibiotics that affect a wide range of microorganisms are called broad-spectrum antibiotics and those that affect only a few types of microorganisms are called narrow-spectrum antibiotics. The Global Antibiotics market is growing at a CAGR of 1.41 percent during the forecast period.
The latest report by TechNavio focuses on the increasing global aging population. The elderly are more likely to acquire infections and require hospitalization, and this is one of the major factors driving moderate growth in this market. The report also emphasizes the ever-increasing demand for antibiotics.
“The increase in demand for antibiotics to counter growing cases of drug-resistant infections offers ideal opportunities for pharmaceutical companies to introduce new products in the marketplace. New approval pathways like the Special Population Limited Medical Use (SPLMU) would authorize the FDA to approve drugs to treat drug-resistant, life-threatening infections with limited available therapies centered on small, rapid and relatively inexpensive clinical trials. This would ensure drugs approved by this mechanism would be available at a premium price,” says Faisal Ghaus, Vice President of TechNavio.
Key Information Covered in the Report:
Market segmentation, size and forecast through 2018
Market Growth Drivers:
- Increasing Global Aging Population
- For a full detailed list, view our report.
Market Challenges:
- Emergence of Drug-resistant Strains
- For a full detailed list, view our report.
Market Trends:
- Increase in Demand for Antibiotics
- For a full detailed list, view our report.
Key Vendors:
- AstraZeneca plc
- Eli Lilly & Co.
- GlaxoSmithKline plc
- Johnson & Johnson Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi
Other Prominent Vendors:
- Bayer HealthCare
- Bristol-Myers Squibb
- Cubist Pharmaceuticals
- Daiichi Sankyo
- F. Hoffmann-La Roche
- Takeda Pharmaceutical
https://www.technavio.com/%3Cp%3E%3Ca%20href%3D%22http%3A//www.technavio….
